Medical Safety Issues

Evidence: US Healthcare, Third Leading Cause of Death_Institute of Medicine, JAMA, 2000

ByVera Sharav November 30, 2009November 21, 2014

Click here for full article

AHRP Speaks Out | CDC Failures | Children at Risk | Clinical Trials | Concealed Data | Concealed Risks | Corrupt Public Health | Corrupted Science | Covid Pandemic | Current Controversies | Global Public Health Institutions | Newsflash | Vaccine Controversies | Vaccine mandates | Vaccine Risks | Vaccine Safety

CDC Officials Concealed Millions of Adverse Events Reported to CDC V-Safe System Following Covid Jabs
October 10, 2022January 26, 2023

CDC Officials Concealed Millions of Adverse Events Reported to CDC V-Safe System Following Covid Jabs Legal action by ICAN and The Highwire forced CDC officials to disclose the concealed evidence of harm caused by the experimental Covid mRNA injections. After a year of legal battles officials at the U.S. Centers for Disease Control…

Read More CDC Officials Concealed Millions of Adverse Events Reported to CDC V-Safe System Following Covid Jabs
Psych Drugs

FDA Suspends ADHD Drug Safety Study-Approves Risperdal for Autistic Children Without Public Hearing
October 9, 2006November 21, 2014

Two actions by the FDA last week demonstrate where the agency’s priority lies—and that priority is NOT to protect public safety, NOT to protect children’s safety. FDA’s priority—as demonstrated by its actions—is approval of new drugs or approval for expanded even dubious uses of patented drugs.

Read More FDA Suspends ADHD Drug Safety Study-Approves Risperdal for Autistic Children Without Public Hearing
Publication Integrity

AHRP Hits JAMA, Seeks Inquiry_WSJ
March 26, 2009November 21, 2014

"The Alliance for Human Research Protection, which is often critical of industry-academic ties, made the requests in a letter it sent Wednesday to the AMA and the journal, also known as JAMA."

Read More AHRP Hits JAMA, Seeks Inquiry_WSJ
Medical Safety Issues

FDA Approval process under fire–PML: Lethal side-effect–Tysabri: Multiple Sclerosis Drug
March 3, 2006November 21, 2014

“When Anita Louise Smith enrolled in an experimental drug trial in 2002 in Colorado, she had a diagnosis of multiple sclerosis but no symptoms and was looking to reduce the chances of being ravaged by the disease. Last year, she died at the age of 46 from an infection linked to the drug.”

Read More FDA Approval process under fire–PML: Lethal side-effect–Tysabri: Multiple Sclerosis Drug
Publication Bias

Journals Must Exercise Their Authority as Gatekeepers
August 1, 2006November 21, 2014

The harm done by journals’ failure to protect the integrity of science can hardly be overstated.

Read More Journals Must Exercise Their Authority as Gatekeepers
Miscellaneous

$95 billion a year spent on medical research in US – JAMA
October 26, 2006November 21, 2014

$95 billion a year spent on medical research in US – JAMA Fri, 23 Sep 2005 A special issue of the Journal of the American Medical Association, JAMA, focuses on medical research spending and findings. A study that examined US spending for medical research—$95 billion approaching $100 billion–57% is spent…

Read More $95 billion a year spent on medical research in US – JAMA

Similar Posts